Substance Abuse Treatment Staff Perceptions of Intimate Partner Victimization Among Female Clients

Kunins, Hillary V.; Gilbert, Louisa; Whyte-Etere, Antonette; Meißner, Paul; Zachary, Mary J.

doi:10.1080/02791072.2007.10400611

Cited by 17 publications

(17 citation statements)

References 17 publications

(12 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study among staff in Canada found that when accessing health and harm reduction services, people with experience of intimate partner violence encounter stigmatising or victim-blaming attitudes [ 55 ]. Under-resourced staff, both in terms of training and high caseloads, reduces the likelihood that intimate partner violence will be addressed [ 58 ]. The lack of services for people with experience of intimate partner violence is an unmet need in harm reduction services.…”

Section: Methodsmentioning

confidence: 99%

Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain

Shirley-Beavan¹,

Roig²,

Burke-Shyne³

et al. 2020

Harm Reduct J

View full text Add to dashboard Cite

Background There are an estimated 3.2 million women who inject drugs worldwide, constituting 20% of all people who inject drugs. The limited data that are available suggest that women who inject drugs are at greater risk of HIV and viral hepatitis acquisition than men who inject drugs. This increased vulnerability is a product of a range of environmental, social and individual factors affecting women, which also affect their ability to engage in health promoting services such as harm reduction. Methods The researchers undertook a narrative literature review examining access to harm reduction services for women who use drugs in Europe and conducted semi-structured focus groups with women who use drugs and harm reduction and prison health workers in Barcelona, Spain. Results Women who use drugs face multiple barriers to accessing harm reduction services. These include stigma, both in society in general and from health and harm reduction workers in prisons and in the community; gender-based violence and a lack of services that are equipped to address the interaction between drug use and experiences of violence; criminalisation in the form of legal barriers to access, arrest and harassment from law enforcement, and incarceration; and a lack of services focused on the specific needs of women, notably sexual and reproductive health services and childcare. In Barcelona, participants reported experiencing all these barriers, and that their engagement with the Metzineres harm reduction centre had to some extent mitigated them. However, women continued to experience structural barriers to harm reduction service access. Conclusions Women and gender non-conforming people who use drugs face unique barriers to accessing harm reduction services. While services such as Metzineres can be life changing and life affirming for its members, it is incumbent on states to act to address the structural barriers to health faced by women who use drugs.

show abstract

Section: Methodsmentioning

confidence: 99%

Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain

Shirley-Beavan¹,

Roig²,

Burke-Shyne³

et al. 2020

Harm Reduct J

View full text Add to dashboard Cite

show abstract

“…These barriers include overburdened staff, lack of private screening space, lack of reimbursement for services, lack of adequate training of staff, lack of access to IPV referrals, and perceived lack of confidentiality. 28,29 Given the multiple barriers for providers screening for IPV and substance use in emergency or primary care settings, there may be significant advantages to using self-paced computerized IPV screening tools. Accumulating research among women in health care settings has found that selfpaced computerized screening interviews are effective in increasing rates of IPV disclosure.…”

Section: Ipv and Suds: Mental And Physical Health Comorbiditiesmentioning

confidence: 99%

Identifying and Intervening with Substance-Using Women Exposed to Intimate Partner Violence: Phenomenology, Comorbidities, and Integrated Approaches Within Primary Care and Other Agency Settings

Weaver

Gilbert²,

El‐Bassel³

et al. 2015

Journal of Women's Health

Self Cite

View full text Add to dashboard Cite

Substance use and/or disorders (SUDs) have been identified as a significant correlate of intimate partner violence (IPV) exposure and present complex issues that intersect with the topography of IPV, attendant mental health, and physical co-morbidities and may pose barriers to primary care-and other agency-based screening and intervention efforts. Despite substantial research indicating significantly higher rates of all types and severity of IPV victimization among women with SUDs and bidirectional associations between partner or selfuse of drugs or alcohol and IPV victimization, effective screening, brief interventions, coordinated systems of care, and treatment approaches to address these co-occurring problems remain very limited. We integrated select research examining the intersection of IPV victimization and SUDs and several comorbidities that have significant public health impact and provided recommendations for scaling up targeted interventions to redress these co-occurring problems among women in primary, emergency, and other care settings.

show abstract

“…This may be explained by high counselor caseloads, a lack of training of program staff to assess for IPV, few resources, and a scarcity of treatment approaches in substance abuse programs to deal with IPV (Kunins, Gilbert, Whyte, Meissner, & Zachary, 2007). Referrals may not occur because the number of IPV treatment programs or battered women's shelters that will accept drug-involved women is low.…”

Section: Challenges Drug Treatment Programs Face In Dealing With Ipv mentioning

confidence: 99%

Intimate Partner Violence and HIV Among Drug-Involved Women: Contexts Linking These Two Epidemics—Challenges and Implications for Prevention and Treatment

El‐Bassel

Gilbert

Witte

et al. 2011

Substance Use & Misuse

Self Cite

133

141

View full text Add to dashboard Cite

Intimate partner violence (IPV) and HIV are two serious overlapping public health epidemics that disproportionately affect drug-involved women. This article reviews research that has identified a number of contexts that may explain the links between IPV and HIV transmission risks. These contexts include sexual coercion, fear of violence, negotiation of condom use, extradyadic relationships, disclosure of sexually transmitted infections or HIV seropositivity to intimate partners, drug involvement of women and their male partners, low social status of drug-involved women, relationship dependencies, and sex ratio imbalances. The article focuses on how the bidirectional relationship between IPV and HIV risks may be mediated by a history of childhood sexual abuse and post-traumatic stress disorder. Also addressed are the challenges that substance user treatment programs face in dealing with female clients who experience IPV and the implications for HIV prevention.

show abstract

Substance Abuse Treatment Staff Perceptions of Intimate Partner Victimization Among Female Clients

Cited by 17 publications

References 17 publications

Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain

Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain

Identifying and Intervening with Substance-Using Women Exposed to Intimate Partner Violence: Phenomenology, Comorbidities, and Integrated Approaches Within Primary Care and Other Agency Settings

Intimate Partner Violence and HIV Among Drug-Involved Women: Contexts Linking These Two Epidemics—Challenges and Implications for Prevention and Treatment

Contact Info

Product

Resources

About